| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 134.24B | 133.07B | 126.98B | 119.07B | 107.14B | 96.63B |
| Gross Profit | 36.09B | 35.93B | 34.23B | 32.71B | 28.22B | 24.42B |
| EBITDA | 19.23B | 19.12B | 18.02B | 16.88B | 13.37B | 10.79B |
| Net Income | 12.85B | 12.74B | 12.34B | 12.25B | 9.24B | 7.03B |
Balance Sheet | ||||||
| Total Assets | 80.83B | 93.61B | 90.76B | 84.98B | 82.00B | 75.45B |
| Cash, Cash Equivalents and Short-Term Investments | 42.30B | 53.01B | 52.74B | 51.03B | 49.71B | 45.13B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 37.24B | 44.83B | 43.06B | 38.26B | 36.71B | 30.98B |
| Stockholders Equity | 43.59B | 48.78B | 47.70B | 46.72B | 45.29B | 44.47B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 13.31B | 14.56B | 12.68B | 13.46B | 5.42B |
| Operating Cash Flow | 0.00 | 13.45B | 14.67B | 12.81B | 13.53B | 5.49B |
| Investing Cash Flow | 0.00 | -998.00M | -1.06B | -446.00M | -270.00M | -307.00M |
| Financing Cash Flow | 0.00 | -12.19B | -11.89B | -11.04B | -8.69B | -7.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
85 Outperform | ¥237.03B | 16.33 | 28.98% | 5.57% | 3.27% | 14.01% | |
83 Outperform | ¥89.03B | 29.69 | ― | 3.53% | 8.72% | 7.78% | |
79 Outperform | ¥109.42B | 13.47 | ― | 7.51% | 2.46% | -30.86% | |
73 Outperform | ¥9.99T | 21.38 | 27.29% | 0.27% | 1.67% | 30.29% | |
66 Neutral | ¥528.76B | 15.57 | 19.18% | 3.59% | 6.79% | 10.35% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
42 Neutral | ¥60.31B | -14.96 | -6.02% | 0.77% | -3.21% | -104.97% |